Form 8-K Immunovant, Inc. For: Mar 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Citi Reiterates Buy Rating on Immunovant (IMVT)
March 20, 2025 6:07 AM EDTCiti analyst Samantha Semenkow reiterated a Buy rating and $58.00 price target on Immunovant (NASDAQ: IMVT).
The analyst comments "Following yesterdays release of topline gMG data (see our take here), the most frequent piece of pushback weve received from investors is that... More



